+100%-

No one suspected a 50 year old kidney drug called spironolactone might hold the key to a new generation of herpesvirus drugs.

University of Utah researchers hoped their new assay might uncover a new way to treat EBV infections – but they were shocked at what it turned up. How could a 50 year old kidney drug called Spironolactone have anything to do with EBV?

 
Four years later they knew how – and the possibility for a more effective drug to treat herpesvirus infections was borne.
 
The moral to this story – you never know where an answer may come from. It could even be sitting on an aisle in your pharmacy.
 
Find out more in a Simmaron Research Foundation sponsored blog:
 

 

Health Rising’s Quickie Summer Donation Drive is On!

Keeping up with the latest research in ME/CFS, long COVID, fibromyalgia, and allied diseases. Exploring new treatment possibilities. Learning how others have recovered. All in as thoroughly and comprehensively as we can. 

Please support Health Rising during our quickie summer donation drive. Our goal is to raise $15,000. 

 Find out more here.

Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.

Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News

Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities. 

Thank you for signing up!

Pin It on Pinterest

Share This